Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Systemic auto-inflammatory manifestations in patients with spondyloarthritis
Avtorji:ID Gaggiano, Carla (Avtor)
ID Zajc Avramovič, Mojca (Avtor)
ID Vitale, Antonio (Avtor)
ID Emeršič, Nina (Avtor)
ID Sota, Jurgen (Avtor)
ID Toplak, Nataša (Avtor)
ID Gentileschi, Stefano (Avtor)
ID Caggiano, Valeria (Avtor)
ID Tarsia, Maria (Avtor)
ID Markelj, Gašper (Avtor)
ID Vesel, Tina (Avtor)
ID Koren Jeverica, Anja (Avtor)
ID Avčin, Tadej (Avtor), et al.
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (1,37 MB)
MD5: 87AD95768E8A14E21F47B68919D79C7B
 
URL URL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S1297319X24000836
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKC LJ - Univerzitetni klinični center Ljubljana
Povzetek:Objectives. – (1) characterizing a group of spondyloarthritis (SpA) patients with systemic autoinflammatory symptoms (S-SpA); (2) comparing SpA features with and without auto-inflammatory symptoms; (3) comparing the auto-inflammatory features of S-SpA and Still’s disease (SD). Methods. – Retrospective observational study. Clinical data of adult and pediatric patients with S-SpA, SD or SpA were collected retrospectively and analyzed. Results. – Forty-one subjects with S-SpA, 39 with SD and 42 with SpA were enrolled. The median latency between systemic and articular manifestations in S-SpA was 4.4 (IQR: 7.2) years. S-SpA and SpA had similar frequency of peripheral arthritis and enthesitis (N.S.), while tenosynovitis was more frequent(P = 0.01) and uveitis less frequent (P < 0.01) in S-SpA. MRI showed signs of sacroiliac inflammation and damage in both S-SpA and SpA equally (N.S.). S-SpA patients had less corner inflammatory lesions (P < 0.05) and inflammation at the facet joints (P < 0.01), more interspinous enthesitis (P = 0.01) and inter-apophyseal capsulitis (P < 0.01). Compared to SD, S-SpA patients had lower-grade fever (P < 0.01), less rash (P < 0.01) and weight loss (P < 0.05), but more pharyngitis (P < 0.01), gastrointestinal symptoms (P < 0.01) and chest pain (P < 0.05). ESR, CRP, WBC, ANC, LDH tested higher in SD (P < 0.01). Resolution of systemic symptoms was less frequent in S-SpA than SD on corticosteroid (P < 0.01) and methotrexate (P < 0.05) treatment. When considering all SD patients, a complete response to corticosteroids in the systemic phase significantly reduced the likelihood of developing SpA (OR = 0.06, coefficient −2.87 [CI: −5.0 to −0.8]). Conclusions. – SpA should be actively investigated in patients with auto-inflammatory manifestations, including undifferentiated auto-inflammatory disease and SD
Ključne besede:spondyloarthritis, febrile spondyloarthritis, Still’s disease, systemic juvenile idiopathic arthritis, adult-onset Still’s disease, auto-inflammatory diseases
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2024
Št. strani:str. 1-10
Številčenje:Vol. 91, iss. 2, [article no.] 105772
PID:20.500.12556/DiRROS-24654 Novo okno
UDK:616-002
ISSN pri članku:1297-319X
DOI:10.1016/j.jbspin.2024.105772 Novo okno
COBISS.SI-ID:212370947 Novo okno
Opomba:
Datum objave v DiRROS:10.12.2025
Število ogledov:72
Število prenosov:30
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Joint bone spine
Skrajšan naslov:Jt. bone spine
Založnik:Editions Elsevier
ISSN:1297-319X
COBISS.SI-ID:1472277 Novo okno

Gradivo je financirano iz projekta

Financer:EC - European Commission
Številka projekta:825575
Naslov:European Joint Programme on Rare Diseases
Akronim:EJP RD

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Nazaj